Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Therapy Cells Inc

+ Add to Watchlist

TCEL:US

0.0006 USD 0.0001 20.00%

As of 20:10:04 ET on 05/26/2015.

Snapshot for Therapy Cells Inc (TCEL)

Open: 0.0005 Day's Range: 0.0005 - 0.0006 Volume: 44,949,523
Previous Close: 0.0005 52wk Range: 0.0002 - 0.0074 1-Yr Rtn: -78.67%

Stock Chart for TCEL

No chart data available.
  • TCEL:US 0.0006
  • 1D
  • 1M
  • 1Y
0.0005
Interactive TCEL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TCEL

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume 22,798,164
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TCEL

No data available

Company Profile & Key Executives for TCEL

Therapy Cells, Inc. researches and develops a method of tissue transplantation to aid in the repair and regeneration of damaged, diseased, torn or ruptured musculoskeletal cells and organs. The Company developed a method to grow tendon and articular cartilage for auto transplantation into individual patients.

Christopher GloverCEO/SecretaryLorne R GaleCFO/Treasurer
More Company Profile & Key Executives for TCEL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil